Tosymra Nasal Spray 10 mg is a Proprietary Acute Migraine Treatment Approved Under the 505(b)2 Pathway Based on Bioequivalence to Imitrex (sumatriptan) Injection 4 mg GlaxoSmithKline Recently Notified ...

Zogenix, Inc. a pharmaceutical company commercializing and developing products for the treatment of central nervous system disorders and pain, confirmed that a recently issued patent (US patent number ...

The US Food and Drug Administration (FDA) has approved Antares Pharma, Inc's Abbreviated New Drug Application (ANDA) for 4 mg/0.5 ml and 6 mg/0.5 ml Sumatriptan injection USP in adults for the acute ...

When you get a migraine attack, you want relief right away. For many people, that relief comes from sumatriptan (Imitrex), the original triptan medication. Despite the development of more triptans and ...

Dr. Reddy's Laboratories (NYSE: RDY), announced today that the U.S. Food and Drug Administration (FDA) has approved ZEMBRACE™SymTouch™ (sumatriptan succinate) injection, a drug-device combination ...

(MENAFN- globenewswire - nasdaq) zembrace® symtouch® (sumatriptan injection) and tosymra® (sumatriptan nasal spray) are indicated for the treatment of acute migraine in adults strategic acquisition ...